Point72 Asset Management, L.P. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,925,009
+3.9%
9,007,0000.0%0.05%0.0%
Q2 2023$15,327,332
-12.2%
9,007,0000.0%0.05%
-14.8%
Q1 2023$17,447,371
+3.8%
9,007,0000.0%0.05%
-5.3%
Q4 2022$16,802,227
+12.2%
9,007,0000.0%0.06%
-5.0%
Q3 2022$14,980,000
-30.4%
9,007,000
-47.0%
0.06%
-34.1%
Q2 2022$21,534,000
-3.7%
17,007,0000.0%0.09%
+2.2%
Q1 2022$22,352,000
+60.3%
17,007,000
+78.9%
0.09%
+58.9%
Q4 2021$13,948,0009,507,0000.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DLD Asset Management, LP 10,370,000$18,432,6751.98%
Worth Venture Partners, LLC 1,431,000$2,536,6771.50%
CSS LLC/IL 8,197,000$14,535,1420.95%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,198,000$9,252,6470.20%
Warberg Asset Management LLC 517,000$911,5800.18%
BOOTHBAY FUND MANAGEMENT, LLC 3,889,000$6,893,8770.16%
PALISADE CAPITAL MANAGEMENT, LP 1,000,000$1,765,6250.05%
Point72 Asset Management, L.P. 9,007,000$15,925,0090.05%
CAPSTONE INVESTMENT ADVISORS, LLC 5,082,000$8,984,9760.04%
D. E. Shaw & Co., Inc. 11,089,000$19,645,1130.02%
View complete list of SAREPTA THERAPEUTICS INC shareholders